0000000000391820

AUTHOR

Darja Isajeva

showing 5 related works from this author

Mildronate enhances learning/memory and changes hippocampal protein expression in trained rats.

2013

Previously we demonstrated that mildronate [3-(2,2,2-trimethylhydrazinium) propionate dihydrate], a representative of the aza-butyrobetaine class of compounds, protects mitochondrial metabolism under conditions such as ischemia. Mildronate also acted as a neuroprotective agent in an azidothymidine-induced mouse model of neurotoxicity, as well as in a rat model of Parkinson's disease. These observations suggest that mildronate may stimulate processes involved in cell survival and change expression of proteins involved in neurogenic processes. The present study investigated the influence of mildronate on learning and memory in the passive avoidance response (PAR) test and the active condition…

MaleClinical BiochemistryGlutamate decarboxylaseBlotting WesternNerve Tissue ProteinsPharmacologyHippocampal formationToxicologyBiochemistryNeuroprotectionHippocampusBehavioral Neurosciencechemistry.chemical_compoundMemorymedicineAnimalsLearningRats WistarBiological PsychiatryPharmacologyChemistryGlutamate DecarboxylaseNeurotoxicitymedicine.diseaseAcetylcholinesteraseNeural stem cellRatsBromodeoxyuridineAcetylcholinesteraseCholinergicNeuroscienceBromodeoxyuridineMethylhydrazinesPharmacology, biochemistry, and behavior
researchProduct

Poly-ADP ribose polymerase, xanthine oxidase and nitric oxide synthase expression in kidney tissue of experimental diabetes

2014

Background The spatial distribution of inflammatory and DNA reparation markers in the kidney tissue in diabetes is poorly understood. Aim The present study investigated the role of endothelial and inducible nitric oxide synthase (eNOS and iNOS), Poly ADP ribose polymerase (PARP) xanthine oxidase (XO) in the pathogenesis of streptozotocin-induced diabetic changes in the kidney tissue. Methods Diabetes mellitus was induced in rats by a single injection of streptozotocin (STZ) at a dose of 50 mg/kg. The XO, PARP, eNOS and iNOS protein expression in the kidney was studied by immunohistochemistry. Results Obtained results showed that STZ administration incresed the numbers of PARP and XO-positiv…

medicine.medical_specialtyKidneybiologyPoly ADP ribose polymeraseStreptozotocinbiology.organism_classificationmedicine.diseasePathology and Forensic MedicineNitric oxide synthasePathogenesischemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryEnosDiabetes mellitusInternal medicinemedicinebiology.proteinXanthine oxidasemedicine.drugPathology
researchProduct

Mildronate as a Regulator of Protein Expression in a Rat Model of Parkinson’s Disease

2011

Background. Mildronate (3-[2,2,2-trimethylhydrazinium] propionate dihydrate) traditionally is a well-known cardioprotective drug. However, our recent studies convincingly demonstrated its neuroprotective properties. The aim of the present study was to evaluate the influence of mildronate on the expression of proteins that are involved in the differentiation and survival of the nigrostriatal dopaminergic neurons in the rat model of Parkinson’s disease (PD). The following biomarkers were used: heat shock protein 70 (Hsp70, a molecular chaperone), glial cell line-derived nerve growth factor (GDNF, a growth factor promoting neuronal differentiation, regeneration, and survival), and neural cell …

biologybusiness.industryGrowth factormedicine.medical_treatmentSubstantia nigraGeneral MedicineStriatumPharmacologyNeuroprotectionHsp70Nerve growth factornervous systemmedicineGlial cell line-derived neurotrophic factorbiology.proteinmildronate; protein expression; neuroprotectionNeural cell adhesion moleculebusinessMedicina
researchProduct

Increased innate and adaptive immune responses in induced sputum of young smokers

2015

Background and objectives: It is known that chronic obstructive pulmonary disease (COPD) development process is imperceptible and can be asymptomatic for 20 or more years. It is of great importance to diagnose early inflammatory changes that can lead to COPD in young asymptomatic cigarette smokers. The aim of our study was to analyze the cell spectrum of induced sputum (IS) of young cigarette smokers, with emphasis on T-regulatory cells. Materials and methods: A total of 20 healthy nonallergic smokers, 20 nonsmokers and 20 COPD patients were enrolled in the study. After lung function measurements were taken, we performed sputum induction and analyzed sputum cells. We evaluated the cell coun…

Medicine(all)Medicine (General)COPDbusiness.industryChronic obstructive pulmonary diseaseLymphocyteSmokingImmunocytochemistryChronic obstructive pulmonary disease; T regulatory lymphocytes; Sputum induction; Smokingmedicine.diseaseAsymptomaticrespiratory tract diseasesStainingSputum inductionR5-920medicine.anatomical_structureImmune systemAutomotive EngineeringImmunologymedicineSputummedicine.symptombusinessCD8T regulatory lymphocytesMedicina
researchProduct

Comparison of the Effects of Glibenclamide on Metabolic Parameters, GLUT1 Expression, and Liver Injury in Rats With Severe and Mild Streptozotocin-In…

2012

Background and Objective. Glucose transport via GLUT1 protein could be one of additional mechanisms of the antidiabetic action of sulfonylureas. Here, the GLUT1 gene and the protein expression was studied in rats in the course of severe and mild streptozotocin-induced diabetes mellitus and under glibenclamide treatment. Material and Methods. Severe and mild diabetes mellitus was induced using different streptozotocin doses and standard or high fat chow. Rats were treated with glibenclamide (2 mg/kg daily, per os for 6 weeks). The therapeutic effect of glibenclamide was monitored by measuring several metabolic parameters. The GLUT1 mRNA and the protein expression in the kidneys, heart, and l…

Blood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentGene ExpressionDiabetes Mellitus ExperimentalGlibenclamideInternal medicineDiabetes mellitusGlyburideInsulin SecretionmedicineAnimalsHypoglycemic AgentsInsulinRats WistarLiver injuryGlucose Transporter Type 1Kidneybiologybusiness.industryInsulinGlucose transporternutritional and metabolic diseasesGeneral Medicinemedicine.diseaseStreptozotocinRatsSulfonylurea Compoundsmedicine.anatomical_structureEndocrinologyLiverProtein Biosynthesisglibenclamide; GLUT1; kidney; streptozotocin; expressionbiology.proteinGLUT1businessmedicine.drugMedicina; Volume 48; Issue 10; Pages: 78
researchProduct